Patent ID: 6071919
Filing Date: 2000-06-06
Classification: A61K,A61P

Abstract:
A method for treating a disease in a mammal, selected from the group consisting of: an infectious disease; a cancerous tumor; leukemia; and an autoimmune disease, which method comprises: administering to the mammal with the disease, as a biological response modifier, an effective amount in one or more treatments, of a zwitterion composition comprising an amphoteric zwitterion compound or a pharmaceutically acceptable salt thereof, which zwitterion compound is an aliphatic or heterocyclic compound having at least one carbon-nitrogen bond and having an acid group selected from the group consisting of: SO.sub.3 ; PO.sub.3 ; and COO; and an alkaline group selected from the group consisting of: OH; N.sup.+ ; N.sup.+ H; and NH.sub.2.